Skip to main content

PICTON MAHONEY ASSET MANAGEMENT

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1539041 Toronto, A6

Position in TEVA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$31,352,823
+$6,949,057 QoQ
Shares Held
925,408
+14.2% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#89
of 673 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2026
CallValue
$33,880,000
CallShares
1,000,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PICTON MAHONEY ASSET MANAGEMENT holds $70,030,747 across 11 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (44.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
This page
925,408 $31,352,823

All Filings in TEVA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,880,000 1,000,000
2026-06-30 $31,352,823 925,408
2026-03-31 $24,403,766 810,218
2026-03-31 $30,120,000 1,000,000
2025-12-31 $18,125,238 580,751
2025-09-30 $12,481,418 617,892
2025-06-30 $11,976,913 714,613
2025-03-31 $9,173,692 596,857
2024-12-31 $13,954,603 633,149
2024-09-30 $7,570,346 420,108
2024-06-30 $3,225,625 198,500